Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 16;12(1):117.
doi: 10.3390/jpm12010117.

Adipose-Derived Stem Cells for Facial Rejuvenation

Affiliations
Review

Adipose-Derived Stem Cells for Facial Rejuvenation

Agnieszka Surowiecka et al. J Pers Med. .

Abstract

The interest in regenerative medicine is increasing, and it is a dynamically developing branch of aesthetic surgery. Biocompatible and autologous-derived products such as platelet-rich plasma or adult mesenchymal stem cells are often used for aesthetic purposes. Their application originates from wound healing and orthopaedics. Adipose-derived stem cells are a powerful agent in skin rejuvenation. They secrete growth factors and anti-inflammatory cytokines, stimulate tissue regeneration by promoting the secretion of extracellular proteins and secrete antioxidants that neutralize free radicals. In an office procedure, without cell incubation and counting, the obtained product is stromal vascular fraction, which consists of not only stem cells but also other numerous active cells such as pericytes, preadipocytes, immune cells, and extra-cellular matrix. Adipose-derived stem cells, when injected into dermis, improved skin density and overall skin appearance, and increased skin hydration and number of capillary vessels. The main limitation of mesenchymal stem cell transfers is the survival of the graft. The final outcomes are dependent on many factors, including the age of the patient, technique of fat tissue harvesting, technique of lipoaspirate preparation, and technique of fat graft injection. It is very difficult to compare available studies because of the differences and multitude of techniques used. Fat harvesting is associated with potentially life-threatening complications, such as massive bleeding, embolism, or clots. However, most of the side effects are mild and transient: primarily hematomas, oedema, and mild pain. Mesenchymal stem cells that do not proliferate when injected into dermis promote neoangiogenesis, that is why respectful caution should be taken in the case of oncologic patients. A longer clinical observation on a higher number of participants should be performed to develop reliable indications and guidelines for transferring ADSCs.

Keywords: facial rejuvenation; fat graft; liposuction; mesenchymal stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Results of CAL and upper blepharoplasty.
Figure 2
Figure 2
Results of skin improvements 6 months after SVF injection.

References

    1. Daar A.S., Greenwood H.L. A proposed definition of regenerative medicine. J. Tissue Eng. Regen. Med. 2007;1:179–184. doi: 10.1002/term.20. - DOI - PubMed
    1. Avantaggiato A., Palmieri A., Carinci F., Pasin M., Bertuzzi G. Biostimulation and biorevitalization: Effects on human skin fibroblasts. Ann. Oral Maxillofac. Surg. 2013;1:11. doi: 10.13172/2052-7837-1-2-482. - DOI
    1. Gentile P., Garcovich S. Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects. Int. J. Mol. Sci. 2021;22:1538. doi: 10.3390/ijms22041538. - DOI - PMC - PubMed
    1. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin. Oral Implant. Res. 2006;17:212–219. doi: 10.1111/j.1600-0501.2005.01203.x. - DOI - PubMed
    1. Anitua E., Sánchez M., Zalduendo M.M., de la Fuente M., Prado R., Orive G., Andía I. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42:162–170. doi: 10.1111/j.1365-2184.2009.00583.x. - DOI - PMC - PubMed

LinkOut - more resources